Home Contact Sitemap

PedAM

Pediatric Disease Annotations & Medicines




Disease pneumonia
Phenotype C0024117|chronic obstructive pulmonary disease (copd)
Sentences 14
PubMedID- 24130228 Inhaled corticosteroids are known to increase the risk of developing pneumonia in patients with chronic obstructive pulmonary disease (copd), but it is unclear whether this risk varies for different agents, particularly fluticasone and budesonide.
PubMedID- 19843708 chronic obstructive pulmonary disease (copd) is associated with pulmonary inflammation with increased numbers of macrophages located in the parenchyma.
PubMedID- 23445751 Recently it has been suggested that there is a causal association between the use of inhaled corticosteroids (icss) and the risk of developing pneumonia in patients with chronic obstructive pulmonary disease (copd).
PubMedID- 26496284 The association of inhaled corticosteroids (ics) and pneumonia in patients with chronic obstructive pulmonary disease (copd) is still controversial.from the national health insurance database of taiwan, copd cases with history of acute exacerbation (ae) were identified (copd cohort).
PubMedID- 25293857 Clinical studies have suggested that inhaled corticosteroid (ics) increases the frequency of pneumonia in patients with chronic obstructive pulmonary disease (copd).
PubMedID- 24920884 Purpose: complications of pneumonia development in patients with chronic obstructive pulmonary disease (copd) receiving inhaled corticosteroid (ics) therapy have been documented.
PubMedID- 25729735 Here, we report a case of c. lapagei pneumonia in a patient with chronic obstructive pulmonary disease (copd).
PubMedID- 25366026 Daptomycin-induced pneumonitis in a patient with chronic obstructive pulmonary disease (copd).
PubMedID- 24739467 The non-typed forms of h. influenzae (nthi) are generally associated to moderate diseases of the upper respiratory tract in children and pneumonia in adults with chronic obstructive pulmonary disease (copd) or cystic fibrosis [11].
PubMedID- 21622588 Cigarette smoke (cs), the primary risk factor of chronic obstructive pulmonary disease (copd), leads to pulmonary inflammation through interleukin-1 receptor (il-1r)i signalling, as determined using copd mouse models.
PubMedID- 19926996 Purpose of review: the aim was to determine the effects of long-term inhaled corticosteroid use on pneumonia in patients with chronic obstructive pulmonary disease (copd) via systematic searches of medline, embase, isi, regulatory documents and manufacturers' trial registries.
PubMedID- 21962211 Background: an increased incidence of pneumonia in patients with chronic obstructive pulmonary disease (copd) under inhaled corticosteroid (ics) therapy was noticed in previous studies.
PubMedID- 25987742 Inhaled corticosteroids (ics) increase community-acquired pneumonia (cap) incidence in patients with chronic obstructive pulmonary disease (copd) by unknown mechanisms.
PubMedID- 24244086 Several studies have shown that the risk of pneumonia is increased in patients with chronic obstructive pulmonary disease (copd) who are receiving chronic inhaled corticosteroids (ics).

Page: 1